Literature DB >> 31268469

Effect of Aerobic and Resistance Exercise on Cardiac Adipose Tissues: Secondary Analyses From a Randomized Clinical Trial.

Regitse Højgaard Christensen1, Anne-Sophie Wedell-Neergaard1, Louise Lang Lehrskov1, Grit Elster Legaard1, Emma Dorph1, Monica Korsager Larsen1, Natja Launbo1, Sabrina Ravn Fagerlind1, Sidsel Kofoed Seide1, Stine Nymand1, Maria Ball1, Nicole Buchner Vinum1, Camilla Nørfelt Dahl1, Marie Henneberg1, Mathias Ried-Larsen1, Mikael Ploug Boesen2, Robin Christensen3,4, Kristian Karstoft1, Rikke Krogh-Madsen1, Jaya Birgitte Rosenmeier5, Bente Klarlund Pedersen1, Helga Ellingsgaard1.   

Abstract

Importance: Epicardial and pericardial adipose tissues are emerging as important risk factors for cardiovascular disease, and there is a growing interest in discovering strategies to reduce the accumulation of fat in these depots. Objective: To investigate whether a 12-week endurance or resistance training intervention regulates epicardial and pericardial adipose tissue mass. Design, Setting, and Participants: Secondary analysis of a randomized, assessor-blinded clinical trial initiated on August 2016 and completed April 2018. This single-center, community-based study included 50 physically inactive participants with abdominal obesity. Interventions: Participants were randomized to a supervised high-intensity interval endurance training (3 times a week for 45 minutes), resistance training (3 times a week for 45 minutes), or no exercise (control group). Main Outcomes and Measures: Change in epicardial and pericardial adipose tissue mass assessed by magnetic resonance imaging, based on a prespecified secondary analysis plan including 3 of 5 parallel groups.
Results: Of 50 participants (mean [SD] age, 41 [14] years, 10 men [26%]; mean [SD] body mass index [calculated as weight in kilograms divided by height in meters squared], 32 [5]), 39 [78%] completed the study. Endurance training and resistance training reduced epicardial adipose tissue mass by 32% (95% CI, 10%-53%) and 24% (95% CI, 1%-46%), respectively, compared with the no exercise control group (56% [95% CI, 24%-88%]; P = .001 and 48% [95% CI, 15%-81%]; P < .001, respectively). While there was a nonsignificant reduction in pericardial adipose tissue mass after endurance training (11% [95% CI, -5% to 27%]; P = .17), resistance training significantly reduced pericardial adipose tissue mass by 31% (95% CI, 16%-47%; P < .001) when compared with the no exercise control group. Compared with the no exercise control group, there was an increase in left ventricular mass by endurance (20 g [95% CI, 11%-30%]; P < .001) and resistance training (18 g [95% CI, 8%-28%]; P < .001). Other cardiometabolic outcomes remained unchanged after the 12-week trial period. Conclusions and Relevance: In individuals with abdominal obesity, both endurance and resistance training reduced epicardial adipose tissue mass, while only resistance training reduced pericardial adipose tissue mass. These data highlight the potential preventive importance of different exercise modalities as means to reduce cardiac fat in individuals with abdominal obesity. Trial Registration: ClinicalTrials.gov identifier: NCT02901496.

Entities:  

Mesh:

Year:  2019        PMID: 31268469      PMCID: PMC6613292          DOI: 10.1001/jamacardio.2019.2074

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  40 in total

Review 1.  Local and systemic effects of the multifaceted epicardial adipose tissue depot.

Authors:  Gianluca Iacobellis
Journal:  Nat Rev Endocrinol       Date:  2015-04-07       Impact factor: 43.330

2.  Pericardial Fat and CVD: Is All Fat Created Equally?

Authors:  Carl J Lavie; Ahmet Afşin Oktay; Ambarish Pandey
Journal:  JACC Cardiovasc Imaging       Date:  2017-03-15

3.  Alterations in ventricular mass and performance induced by exercise training in man evaluated by echocardiography.

Authors:  A N DeMaria; A Neumann; G Lee; W Fowler; D T Mason
Journal:  Circulation       Date:  1978-02       Impact factor: 29.690

4.  Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate.

Authors:  Regitse H Christensen; Bernt J von Scholten; Christian S Hansen; Sarah E Heywood; Jaya B Rosenmeier; Ulrik B Andersen; Peter Hovind; Henrik Reinhard; Hans-Henrik Parving; Bente K Pedersen; Marit E Jørgensen; Peter K Jacobsen; Peter Rossing
Journal:  Eur J Prev Cardiol       Date:  2017-06-26       Impact factor: 7.804

5.  Effect of Exercise Intervention on Cardiac Function in Type 2 Diabetes Mellitus: A Systematic Review.

Authors:  Maxim Verboven; Lisa Van Ryckeghem; Jamal Belkhouribchia; Paul Dendale; Bert O Eijnde; Dominique Hansen; Virginie Bito
Journal:  Sports Med       Date:  2019-02       Impact factor: 11.136

6.  Effects of resistance training on MRI-derived epicardial fat volume and arterial stiffness in women with obesity: a randomized pilot study.

Authors:  Maria Fernandez-del-Valle; Joaquin U Gonzales; Shelby Kloiber; Sunanda Mitra; Jon Klingensmith; Eneko Larumbe-Zabala
Journal:  Eur J Appl Physiol       Date:  2018-03-27       Impact factor: 3.078

7.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

8.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

9.  The effect of dapagliflozin treatment on epicardial adipose tissue volume.

Authors:  Takao Sato; Yoshifusa Aizawa; Sho Yuasa; Shohei Kishi; Koichi Fuse; Satoshi Fujita; Yoshio Ikeda; Hitoshi Kitazawa; Minoru Takahashi; Masahito Sato; Masaaki Okabe
Journal:  Cardiovasc Diabetol       Date:  2018-01-04       Impact factor: 9.951

10.  The role of exercise combined with tocilizumab in visceral and epicardial adipose tissue and gastric emptying rate in abdominally obese participants: protocol for a randomised controlled trial.

Authors:  Regitse Højgaard Christensen; Anne-Sophie Wedell-Neergaard; Louise Lang Lehrskov; Grit Elster Legård; Emma Berndt Dorph; Stine Nymand; Maria Korf Ball; Morten Zacho; Robin Christensen; Helga Ellingsgaard; Jaya Birgitte Rosenmeier; Rikke Krogh-Madsen; Bente Klarlund Pedersen; Kristian Karstoft
Journal:  Trials       Date:  2018-05-02       Impact factor: 2.279

View more
  16 in total

Review 1.  Treatment of Obesity in Mitigating Metabolic Risk.

Authors:  Sean P Heffron; Johnathon S Parham; Jay Pendse; José O Alemán
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

2.  Cross-Sectional and Longitudinal Associations of Lifestyle Behaviors with Pericardial Adipose Tissue: The MESA Study.

Authors:  Minsuk Oh; David R Jacobs; Kelley Pettee Gabriel; Wei Bao; Gary L Pierce; Lucas J Carr; Jingzhong Ding; Kara M Whitaker
Journal:  Med Sci Sports Exerc       Date:  2022-01-25

Review 3.  Epicardial Adipose Tissue and Cardiac Arrhythmias: Focus on Atrial Fibrillation.

Authors:  Maddalena Conte; Laura Petraglia; Serena Cabaro; Vincenza Valerio; Paolo Poggio; Emanuele Pilato; Emilio Attena; Vincenzo Russo; Adele Ferro; Pietro Formisano; Dario Leosco; Valentina Parisi
Journal:  Front Cardiovasc Med       Date:  2022-06-30

Review 4.  Comparison of the Effect of Endurance, Strength, and Endurance-Strength Training on Inflammatory Markers and Adipokines Levels in Overweight and Obese Adults: Systematic Review and Meta-Analysis of Randomised Trials.

Authors:  Aleksandra Makarewicz; Małgorzata Jamka; Jakub Geltz; Angelika Śmidowicz; Marta Kokot; Nina Kaczmarek; Edyta Mądry; Jarosław Walkowiak
Journal:  Healthcare (Basel)       Date:  2022-06-13

5.  Associations of Abdominal and Cardiovascular Adipose Tissue Depots With HDL Metrics in Midlife Women: the SWAN Study.

Authors:  Alexis Nasr; Karen Matthews; Imke Janssen; Maria M Brooks; Emma Barinas-Mitchell; Trevor J Orchard; Jeffrey Billheimer; Norman C Wang; Dan McConnell; Daniel J Rader; Samar R El Khoudary
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

6.  Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease.

Authors:  Mohammed Eslam; Jacob George
Journal:  Hepatol Int       Date:  2019-10-04       Impact factor: 6.047

7.  Role of Perivascular Adipose Tissue and Exercise on Arterial Function with Obesity.

Authors:  Samuel Y Boateng; I Mark Olfert; Paul D Chantler
Journal:  Exerc Sport Sci Rev       Date:  2021-07-01       Impact factor: 6.642

8.  Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes.

Authors:  Regitse H Christensen; Bernt Johan von Scholten; Christian S Hansen; Magnus T Jensen; Tina Vilsbøll; Peter Rossing; Peter G Jørgensen
Journal:  Cardiovasc Diabetol       Date:  2019-08-30       Impact factor: 9.951

9.  High Intensity Resistance Exercise Training vs. High Intensity (Endurance) Interval Training to Fight Cardiometabolic Risk Factors in Overweight Men 30-50 Years Old.

Authors:  Michael Tuttor; Simon von Stengel; Matthias Kohl; Michael Lell; Michael Scharf; Michael Uder; Andreas Wittke; Wolfgang Kemmler
Journal:  Front Sports Act Living       Date:  2020-06-16

Review 10.  Muscle-Organ Crosstalk: The Emerging Roles of Myokines.

Authors:  Mai Charlotte Krogh Severinsen; Bente Klarlund Pedersen
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.